Net Cash Provided by (Used in) Operating Activities |
-358K |
USD |
-12847% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
3B |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
423K |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-358K |
USD |
-12847% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
28.4M |
USD |
-19.8% |
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Valuation Allowance |
2.92M |
USD |
+195% |
Q4 2023 |
FY 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0 |
pure |
|
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Gross |
2.92M |
USD |
+195% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
12.2K |
USD |
+1683% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Authorized |
1M |
shares |
|
Q3 2023 |
Q3 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2024 |
Q3 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2023 |
Q3 2023 |